Contact Us

Tribal

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Tribal

Jan 15, 2025

2024 China-ASEAN College Students' AI Application Innovation, Recruitment is starting now!

Free registration with generous rewards! High winning rate,and professional project guidance throughout the entire process!

Tribal

Jan 15, 2025

Picarro Broadens Initiative to Enable Sterilization Facilities to Streamline Ethylene Oxide Emissions Compliance Ahead of New EPA NESHAP Rule

Program includes 2nd Annual EtO Compliance Conference,expanded educational resources,and enhanced solutions and expert services

Tribal

Jan 15, 2025

Sixty Percent of Employees Plan to Move Jobs This Year, Aon Study Finds

Inaugural study of employees in 23 geographies reveals employees are engaging in a "hustle reset" as they reassess where and how much they work

Tribal

Jan 15, 2025

ZTE, Nokia, and Huawei Lead ABI Research's 5G FWA CPE Vendor Competitive Ranking

LONDON,Jan. 14,2025-- A new Competitive Ranking by global technology intelligence firm ABI Research has found that ZTEis the leading 5G FWA CPE vendor,beating both Nokia and Huawei for the top spot o

Tribal

Jan 15, 2025

Cision Welcomes Guy Abramo as New Chief Executive Officer

CHICAGO,Jan. 15,2025--Cision,a leader in consumer and media intelligence solutions,is pleased to announce the appointment of Guy Abramo as its new Chief Executive Officer,effective immediately.

Tribal

Jan 15, 2025
1 ... 124 125 126 127 128 129 130 ... 132